Assets Changement Date
Abbott USD 73.35B 440M 2023-06
Agilent USD 10.95B 185M 2023-12
AtriCure USD 613.93M 13.66M 2023-12
Baxter International USD 28.28B 2.38B 2023-12
Becton, Dickinson and Co. USD 52.27B 506M 2023-12
Bio-Rad Laboratories USD 12.3B 403.13M 2023-12
Boston Scientific USD 34.04B 442M 2023-09
Cooper Companies USD 12.03B 373.7M 2023-12
Danaher USD 84.49B 3.25B 2023-12
Dexcom USD 6.26B 331.7M 2023-12
Edwards Lifesciences USD 9.36B 7.6M 2023-12
Globus Medical USD 5.09B 269.79M 2023-12
Hologic USD 8.47B 669.8M 2023-12
Insulet USD 2.59B 120.5M 2023-12
Integra LifeSciences USD 3.78B 42.62M 2023-12
Intuitive Surgical USD 15.44B 728.8M 2023-12
J&J USD 166.06B 25.62B 2023-09
Masimo USD 3.04B 45.6M 2023-12
Merit Medical Systems USD 2.33B 516.74M 2023-12
Pfizer USD 215.02B 5.15B 2023-09
Smith & Nephew USD 9.84B 122M 2023-06
Stryker USD 39.88B 1.84B 2023-12
Tandem Diabetes Care USD 952.66M 12.75M 2023-12
Teleflex USD 7.53B 38.91M 2023-12
Terumo JPY 1.75T 77.6B 2023-09
Thermo Fisher Scientific USD 98.73B 1.67B 2023-12
Zimmer Biomet Holdings USD 21.5B 279.6M 2023-12



Abbott Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.